State of Michigan Retirement System Has $8.30 Million Stake in Humana Inc. (NYSE:HUM)

State of Michigan Retirement System reduced its holdings in Humana Inc. (NYSE:HUM) by 0.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 32,725 shares of the insurance provider’s stock after selling 100 shares during the period. State of Michigan Retirement System’s holdings in Humana were worth $8,303,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Schechter Investment Advisors LLC acquired a new position in shares of Humana in the 4th quarter valued at $244,000. Fidelis Capital Partners LLC bought a new stake in Humana in the fourth quarter valued at about $225,000. Jones Financial Companies Lllp lifted its stake in Humana by 68.1% in the fourth quarter. Jones Financial Companies Lllp now owns 2,029 shares of the insurance provider’s stock valued at $515,000 after buying an additional 822 shares during the period. Asahi Life Asset Management CO. LTD. bought a new position in Humana during the fourth quarter worth about $360,000. Finally, Kinsale Capital Group Inc. grew its position in shares of Humana by 15.7% during the 4th quarter. Kinsale Capital Group Inc. now owns 13,626 shares of the insurance provider’s stock worth $3,457,000 after buying an additional 1,849 shares during the period. 92.38% of the stock is owned by institutional investors.

Humana Stock Down 0.3 %

Shares of HUM stock opened at $262.10 on Thursday. The firm’s fifty day moving average price is $271.53 and its two-hundred day moving average price is $284.92. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $406.46. The firm has a market capitalization of $31.62 billion, a P/E ratio of 26.34, a PEG ratio of 2.05 and a beta of 0.57.

Humana (NYSE:HUM) last released its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. On average, equities analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.35%. The ex-dividend date is Friday, March 28th. Humana’s payout ratio is presently 35.58%.

Analyst Ratings Changes

A number of analysts recently weighed in on HUM shares. Truist Financial increased their price target on shares of Humana from $260.00 to $290.00 and gave the company a “hold” rating in a research report on Monday, January 6th. Royal Bank of Canada reiterated an “outperform” rating and issued a $283.00 target price on shares of Humana in a report on Wednesday, February 12th. StockNews.com cut shares of Humana from a “buy” rating to a “hold” rating in a research report on Wednesday. Morgan Stanley lowered their price objective on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a research report on Wednesday, February 12th. Finally, Cantor Fitzgerald reiterated a “neutral” rating and set a $290.00 target price on shares of Humana in a report on Wednesday, February 12th. Twenty investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat, Humana has a consensus rating of “Hold” and an average target price of $285.68.

Insider Activity at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the sale, the insider now directly owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.32% of the stock is owned by company insiders.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.